Question 1 · Medium
A 60-year-old man develops a wound infection 5 days after hip replacement in a Pune hospital. Culture grows Staphylococcus aureus resistant to cefoxitin (disc diffusion) and oxacillin. The resident writes four statements: 1. Resistance is due to PBP2a, coded by the mecA gene. 2. Vancomycin acts by binding the D-Ala-D-Ala end of cell wall precursors. 3. Amoxicillin-clavulanate will work because clavulanate inactivates the resistance enzyme. 4. Linezolid, an alternative, can cause thrombocytopenia when given for more than 2 weeks. Which statements are correct?
- A1, 2 and 3 only
- B1, 2 and 4 only
- C2, 3 and 4 only
- D1 and 2 only
Show answerHide answer
Answer: B · 1, 2 and 4 only
Statements 1, 2 and 4 are correct. MRSA carries mecA, which codes for PBP2a, a transpeptidase with low affinity for beta-lactams; cefoxitin is the laboratory marker because it induces mecA well. Vancomycin binds the D-Ala-D-Ala terminus of peptidoglycan precursors and blocks their incorporation, and linezolid, which binds the 50S ribosomal subunit, causes reversible myelosuppression, mainly thrombocytopenia, with prolonged courses. Statement 3 is false: the resistance is not due to a beta-lactamase, so adding clavulanate does not help; ceftaroline is a beta-lactam that does bind PBP2a.
- A: Includes statement 3; a beta-lactamase inhibitor cannot overcome an altered PBP.
- C: Includes statement 3 and omits statement 1, the actual mechanism of MRSA.
- D: Omits the linezolid adverse effect in statement 4, which is correct.